Can Diabetics Drink Tart Cherry Juice?

Most people with diabetes can include tart cherry juice in their diet, though portion size and product choice matter. Tart cherry juice scores low on the glycemic index, and a small body of research suggests it may modestly benefit blood sugar markers, inflammation, and blood pressure. The evidence is early-stage, though, mostly from pilot studies and short-term trials, so tart cherry juice is better understood as a reasonable beverage choice than as a treatment for diabetes.

A Low Glycemic Index Is the Starting Point

The first concern for anyone managing diabetes is how a food or drink affects blood sugar. Tart cherry juice performs well on this front. Testing of both raw cherries and cherry juice found glycemic index values around 45 to 46, which puts them solidly in the “low” category (anything at or below 55 qualifies).¹ For context, orange juice typically lands in the mid-to-high 50s, and many sports drinks score higher still. One exercise study confirmed this directly: blood glucose stayed lower after consuming tart cherry juice than after a standard sports drink, with the difference persisting for about 40 minutes.²

That said, “low glycemic index” does not mean “no sugar.” An eight-ounce glass of unsweetened tart cherry juice contains roughly 25 to 30 grams of carbohydrate, most of it from natural sugars. If you are counting carbs per meal, that glass uses a meaningful portion of your budget. The low GI simply means those sugars are absorbed more gradually, producing a gentler rise and fall in blood glucose compared to the same amount of carbohydrate from, say, apple juice or a soft drink.

What the Human Evidence Says About Blood Sugar

A handful of trials have looked at tart cherry juice in people with diabetes or metabolic risk factors, and the results are cautiously encouraging. In a pilot study of women with type 2 diabetes who drank concentrated sour cherry juice daily for six weeks, researchers found significant reductions in HbA1c, body weight, and blood pressure.³ HbA1c reflects average blood sugar over two to three months, so a drop there is more meaningful than a one-off glucose reading. The study was small and uncontrolled, which limits how much weight to put on the numbers, but the direction of the effect is noteworthy.

A separate trial in adults with metabolic syndrome found that just six days of Montmorency tart cherry juice supplementation significantly lowered fasting glucose compared to a placebo.⁴ The same study reported reductions in total cholesterol and LDL cholesterol. Metabolic syndrome shares substantial overlap with type 2 diabetes, including insulin resistance and elevated blood sugar, so findings in this group are reasonably relevant.

Animal research adds some biological plausibility. In diabetic rats given cherry extract at a moderate dose for 30 days, blood glucose levels dropped significantly and markers of kidney stress improved.⁵ A mouse study examining anthocyanin-rich tart cherry extract found it did not reverse weight gain or glucose intolerance caused by a high-fat diet, but it did reduce inflammatory markers like IL-6 and leptin while boosting antioxidant capacity.⁶ The takeaway from the animal work is that tart cherry compounds seem to act more on inflammation and oxidative stress than on blood sugar directly, which has its own relevance for people with diabetes.

Inflammation and Why It Matters Here

Chronic low-grade inflammation is a persistent companion of type 2 diabetes. It contributes to insulin resistance itself and accelerates the vascular damage that leads to complications in the eyes, kidneys, nerves, and heart. If tart cherry juice can meaningfully lower inflammation, that alone could be valuable even without dramatic changes to blood sugar numbers.

A systematic review and meta-analysis of randomized trials found that tart cherry significantly reduced C-reactive protein (CRP), a widely used blood marker of inflammation, by an average of about 0.55 mg/L compared to control groups.⁷ The effect on IL-6, another inflammatory marker, was not significant in that analysis. A 12-week trial in older adults specifically reported that tart cherry juice consumption lowered CRP by about 25% and oxidized LDL (a marker tied to artery-clogging plaque) by roughly 11% compared to baseline values.⁸

The picture is not unanimous. A crossover pilot study in overweight and obese adults found that tart cherry juice did not budge hsCRP, IL-6, or IL-10 levels.⁹ The inconsistency likely reflects differences in study duration, dose, and baseline inflammation levels of participants. People who start out with higher inflammation may see more benefit. That matters for diabetes, where systemic inflammation tends to be elevated.

Blood Pressure Effects

High blood pressure is extremely common among people with diabetes and is a major driver of the cardiovascular complications that make the disease dangerous. A trial in men with early hypertension found that Montmorency tart cherry consumption lowered systolic blood pressure significantly over a three-hour period, with a peak reduction of about 7 mmHg at the two-hour mark.¹⁰ A 7-point drop is comparable to what some mild blood pressure medications achieve, though this was measured acutely (right after drinking) rather than as a sustained daily effect.

A longer pilot trial in adults with metabolic syndrome found no significant changes in blood pressure, arterial stiffness, or hemodynamic measures after daily tart cherry juice consumption, though it did note reductions in processes involved in atherosclerosis.¹¹ So the blood pressure story may depend on whether you’re looking at immediate effects or sustained changes over weeks. For someone with diabetes who also has borderline-high blood pressure, the acute benefit is interesting but not something to rely on in place of medication.

Cholesterol and Lipid Effects

A meta-analysis pooling data from randomized controlled trials found that tart cherry juice had no significant overall effect on total cholesterol, triglycerides, LDL, HDL, or insulin levels across the full study population.¹² That sounds discouraging, but the subgroup analyses told a different story: when researchers looked specifically at people who were already metabolically unhealthy, significant improvements appeared in total cholesterol, triglycerides, and LDL.

A more recent dose-response meta-analysis reinforced this pattern. In unhealthy populations specifically, tart cherry lowered total cholesterol, triglycerides, and LDL by clinically meaningful amounts. The favorable effects were more pronounced with longer supplementation, in older adults, and in people with obesity.¹³ Since people with type 2 diabetes frequently have elevated triglycerides and LDL, they fall squarely into the subgroup most likely to benefit. It’s worth noting that these effects were seen at concentrate doses around 20 mL (roughly two-thirds of an ounce of concentrate, which dilutes to a much larger glass), so this is not a case of needing to drink large volumes.

Uric Acid and Gout

Gout and type 2 diabetes often coexist. Insulin resistance drives up uric acid levels, and the medications used to manage one condition sometimes complicate the other. Tart cherry has a longer track record for uric acid reduction than for blood sugar management, and the evidence here is a bit firmer.

A systematic review of cherry and gout research found that tart cherry juice consumed for four weeks significantly reduced plasma urate levels, while the placebo group actually saw an increase.¹⁴ A trial in overweight and obese adults reported that 100% tart cherry juice cut serum uric acid by about 19%.¹⁵ The same study noted that participants had markers of increased cardiovascular risk and insulin resistance, making them a population that looks a lot like many type 2 diabetes patients. For someone managing both diabetes and gout, tart cherry juice addresses two problems with one glass.

Practical Guidance on Portions and Product Selection

The question is less “can diabetics drink this” and more “how much, and which version.” Here is where the details matter:

• Unsweetened only: Many commercial tart cherry juice products contain added sugar or are blended with apple juice to cut the tartness. These can double the carbohydrate content per serving. Read the label for “100% tart cherry juice” or “no added sugars.” Concentrate that you dilute yourself is usually a cleaner option.
• Portion control: Most clinical trials used either 8 ounces of juice or roughly 30 mL of concentrate mixed with water, once or twice daily. Sticking to about one cup or less per serving keeps the carbohydrate load manageable at around 25 to 30 grams.
• Timing: Drinking tart cherry juice with a meal rather than on an empty stomach can further blunt the glycemic response, because the fiber, fat, and protein in the meal slow sugar absorption.
• Counting it in your plan: If you use carb counting to dose insulin, tart cherry juice is no different from any other carbohydrate source: count it, dose for it, and monitor your response.

Some people with diabetes prefer tart cherry supplements in capsule form to avoid the sugar altogether. Capsules deliver the anthocyanins and other polyphenols without the carbohydrate, though the research has mostly been conducted using juice or concentrate rather than capsules, so extrapolating results requires some caution.

When to Be Cautious

Tart cherry juice is not risk-free for everyone. A published case report described a patient with chronic kidney disease who developed acute kidney injury and dangerously high potassium levels after consuming cherry concentrate daily.¹⁶ Stopping the concentrate reversed both problems. Cherries are moderately high in potassium, and concentrated forms pack even more into a small volume. Since diabetes is a leading cause of kidney disease, and many people with long-standing diabetes have some degree of reduced kidney function, this is a real concern. If your kidney function is impaired or you are on a potassium-restricted diet, discuss tart cherry products with your doctor before adding them.

Drug interactions are another consideration. Tart cherry juice contains compounds that can inhibit some of the same liver enzymes responsible for metabolizing medications. While no specific dangerous interactions have been well documented in large trials, people taking blood thinners, blood pressure medications, or drugs with narrow therapeutic windows should be aware that concentrated polyphenol sources can sometimes alter how their body processes those drugs. The practical step is simply to mention it at your next appointment if you start drinking it regularly.

How Processing Affects What You Actually Get

The anthocyanins that give tart cherries their color are also the compounds most often credited with their health effects. These pigments are fragile. Heat treatment of sour cherry juice at 90°C caused anthocyanin losses of roughly 38 to 46%, depending on the cultivar, with lower temperatures causing proportionally less damage.¹⁷ Pasteurization, which most commercial juices undergo, uses temperatures in this range.

Storage matters too. Keeping sour cherry juice at room temperature for six months reduced original anthocyanin concentrations by 70 to 75%.¹⁸ Interestingly, the overall antioxidant capacity of the juice was not affected during that storage period, suggesting that other polyphenols remain active even as anthocyanins break down. Still, if you’re buying tart cherry juice partly for the anthocyanin content, refrigerating it and choosing products with recent bottling dates helps. Frozen tart cherry concentrate tends to retain more of the original compounds than shelf-stable bottled juice that has been sitting in a warehouse.

Sleep, Gut Health, and the Broader Picture

Two areas where tart cherry juice has attracted attention sit slightly outside the diabetes conversation but feed back into it in useful ways. The first is sleep. Tart cherries are one of the few natural food sources of melatonin, and supplementation with tart cherry juice has been shown to significantly raise circulating melatonin levels and improve total sleep time and sleep efficiency.¹⁹ Poor sleep is strongly linked to worsened insulin sensitivity, higher fasting glucose, and increased appetite, so anything that genuinely improves sleep quality can have downstream metabolic benefits for people with diabetes.

The second is the gut microbiome. A study combining lab work and a human trial found that tart cherry polyphenols act as a sort of selective fertilizer for gut bacteria. The response depended heavily on a person’s starting microbiome composition. People who began with low levels of Bacteroides bacteria saw increases in Bacteroides and Bifidobacterium (generally considered beneficial), while people who started with high Bacteroides levels saw shifts in the opposite direction.²⁰ The gut microbiome is increasingly understood to influence glucose metabolism, inflammation, and even how effectively diabetes medications work. The research on tart cherry’s microbiome effects is preliminary, but it points toward a mechanism that could help explain why responses to the juice vary so much from person to person.

What Research Is Still Missing

The honest assessment is that no large, long-term randomized trial has tested tart cherry juice specifically in people with type 2 diabetes as its primary study population. The pilot study in diabetic women is the closest we have, and it was small and uncontrolled. Much of the evidence comes from adjacent populations: people with metabolic syndrome, older adults with elevated inflammation, overweight individuals with insulin resistance. These groups overlap heavily with diabetes, but they are not the same thing.

We also lack good data on dose-response curves in diabetics specifically. The meta-analyses that found favorable lipid effects pointed to about 20 mL of concentrate as a sweet spot, but that finding was across mixed populations. Whether someone on metformin or insulin would see the same magnitude of benefit is simply unknown. And the duration of most trials, often just a few days to a few weeks, leaves open the question of whether the benefits persist or fade with long-term use.

The animal evidence showing that anthocyanins failed to reverse glucose intolerance while still reducing inflammation is a useful reality check. Tart cherry juice is unlikely to be a glucose-lowering powerhouse. Its value for people with diabetes probably lies more in the anti-inflammatory, antioxidant, and cardiometabolic effects than in any direct ability to replace or supplement glucose-lowering medications. Treating it as a nutrient-dense, low-glycemic beverage that may offer some bonus health effects is closer to the evidence than treating it as a diabetes remedy.